Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.
Sarah Doyle, PhD, and Matthew Campbell, PhD, have spent much of their married life doing research together. In this interview (reposted from 2016), they talk about how their partnership began, what continues to drive them, and surprising turns their work has taken on the path to curing diseases of mind and sight.
For a long time we’ve known that hypertension in midlife increases the risk of Alzheimer’s. Now BrightFocus-funded research is exploring that connection – with some surprising results that are relevant to COVID-19.
Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
This resource discusses medical conditions that can affect driving, safe driving tips and strategies, a self test for drivers, evaluation and discussion of unsafe driving practices, and maintaining independence once a decision is made to stop driving.
Dr. Benjamin Kim is Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania. His areas of research expertise include age-related macular degeneration, diabetic retinopathy, geographic atrophy, choroidal neovascularization, retinal neovascularization, clinical trials, and retinal imaging. View the transcript Print the transcript
Co-chairs of the Alzheimer's Fast Track program discuss big challenges that need to be tackled worldwide: Remaining steadfastly committed to funding Alzheimer's disease and related dementias research; Supporting innovative, early-career investigators; Encouraging researchers from under-represented groups who are disproportionately affected by Alzheimer’s to lead independent research labs; and the future of clinical trials, treatments and finding a cure.
November 10, 2020
We are currently supporting more than$35 million Worldwide for Alzheimer's Research
Three scientists – renowned for scientific breakthroughs in Alzheimer’s, macular degeneration and glaucoma and who were given key early support from BrightFocus – have been elected as members of the prestigious National Academy of Medicine.
BrightFocus Foundation, a premier source of private research funding to defeat Alzheimer’s disease, macular degeneration, and glaucoma, today announced the addition of Sharyn Rossi, PhD, to its senior staff as the organization’s new Director of Scientific Programs, Neuroscience.